β-Amyloid Load on PET Along the Continuum of Dementia With Lewy Bodies.
Journal
Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060
Informations de publication
Date de publication:
11 07 2023
11 07 2023
Historique:
received:
08
08
2022
accepted:
23
03
2023
pmc-release:
11
07
2024
medline:
12
7
2023
pubmed:
19
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
β-Amyloid (Aβ) plaques can co-occur with Lewy-related pathology in patients with dementia with Lewy bodies (DLB), but Aβ load at prodromal stages of DLB still needs to be elucidated. We investigated Aβ load on PET throughout the DLB continuum, from an early prodromal stage of isolated REM sleep behavior disorder (iRBD) to a stage of mild cognitive impairment with Lewy bodies (MCI-LB), and finally DLB. We performed a cross-sectional study in patients with a diagnosis of iRBD, MCI-LB, or DLB from the Mayo Clinic Alzheimer Disease Research Center. Aβ levels were measured by Pittsburgh compound B (PiB) PET, and global cortical standardized uptake value ratio (SUVR) was calculated. Global cortical PiB SUVR values from each clinical group were compared with each other and with those of cognitively unimpaired (CU) individuals (n = 100) balanced on age and sex using analysis of covariance. We used multiple linear regression testing for interaction to study the influences of sex and Of the 162 patients, 16 had iRBD, 64 had MCI-LB, and 82 had DLB. Compared with CU individuals, global cortical PiB SUVR was higher in those with DLB ( In this cross-sectional study, levels of Aβ load was higher further along the DLB continuum. Whereas Aβ levels were comparable with those in CU individuals in iRBD, a significant elevation in Aβ levels was observed in the predementia stage of MCI-LB and in DLB. Specifically,
Sections du résumé
BACKGROUND AND OBJECTIVES
β-Amyloid (Aβ) plaques can co-occur with Lewy-related pathology in patients with dementia with Lewy bodies (DLB), but Aβ load at prodromal stages of DLB still needs to be elucidated. We investigated Aβ load on PET throughout the DLB continuum, from an early prodromal stage of isolated REM sleep behavior disorder (iRBD) to a stage of mild cognitive impairment with Lewy bodies (MCI-LB), and finally DLB.
METHODS
We performed a cross-sectional study in patients with a diagnosis of iRBD, MCI-LB, or DLB from the Mayo Clinic Alzheimer Disease Research Center. Aβ levels were measured by Pittsburgh compound B (PiB) PET, and global cortical standardized uptake value ratio (SUVR) was calculated. Global cortical PiB SUVR values from each clinical group were compared with each other and with those of cognitively unimpaired (CU) individuals (n = 100) balanced on age and sex using analysis of covariance. We used multiple linear regression testing for interaction to study the influences of sex and
RESULTS
Of the 162 patients, 16 had iRBD, 64 had MCI-LB, and 82 had DLB. Compared with CU individuals, global cortical PiB SUVR was higher in those with DLB (
DISCUSSION
In this cross-sectional study, levels of Aβ load was higher further along the DLB continuum. Whereas Aβ levels were comparable with those in CU individuals in iRBD, a significant elevation in Aβ levels was observed in the predementia stage of MCI-LB and in DLB. Specifically,
Identifiants
pubmed: 37202168
pii: WNL.0000000000207393
doi: 10.1212/WNL.0000000000207393
pmc: PMC10351554
doi:
Substances chimiques
Amyloid beta-Peptides
0
Apolipoprotein E4
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e178-e188Subventions
Organisme : NINDS NIH HHS
ID : U01 NS100620
Pays : United States
Organisme : NINDS NIH HHS
ID : U24 NS095871
Pays : United States
Informations de copyright
© 2023 American Academy of Neurology.
Références
Neurology. 2017 Jul 4;89(1):88-100
pubmed: 28592453
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Acta Neuropathol. 2015 May;129(5):729-48
pubmed: 25758940
Mov Disord. 2012 Jul;27(8):965-73
pubmed: 22693110
Neurology. 2021 Jan 6;:
pubmed: 33408148
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Neurology. 2008 Sep 16;71(12):903-10
pubmed: 18794492
Neuroepidemiology. 2008;30(1):58-69
pubmed: 18259084
J Alzheimers Dis. 2016;51(4):1069-83
pubmed: 26923009
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
Neurology. 2020 Jan 21;94(3):e282-e291
pubmed: 31862783
J Nucl Med. 2020 Nov;61(11):1628-1635
pubmed: 32198310
JAMA Netw Open. 2019 Dec 2;2(12):e1916439
pubmed: 31790563
Lancet Neurol. 2017 Jan;16(1):55-65
pubmed: 27979356
PET Clin. 2017 Jul;12(3):351-359
pubmed: 28576172
Alzheimers Dement. 2017 Mar;13(3):205-216
pubmed: 27697430
JAMA. 2015 May 19;313(19):1939-49
pubmed: 25988463
Alzheimers Dement (Amst). 2015 Sep 1;1(3):316-324
pubmed: 26405688
Ann Neurol. 2018 May;83(5):1016-1026
pubmed: 29665124
Ann Neurol. 2010 Jan;67(1):122-31
pubmed: 20186853
Am J Geriatr Psychiatry. 2020 May;28(5):573-577
pubmed: 31953009
Neurology. 2018 Sep 18;91(12):e1182-e1195
pubmed: 30143564
Am J Alzheimers Dis Other Demen. 2015 Mar;30(2):173-7
pubmed: 25013117
Ann Neurol. 2020 May;87(5):739-750
pubmed: 32078179
Front Neurol. 2019 Jun 25;10:671
pubmed: 31293508
Int J Geriatr Psychiatry. 2018 Oct;33(10):1293-1304
pubmed: 30091150
Neurology. 2020 Apr 28;94(17):743-755
pubmed: 32241955
Alzheimers Dement. 2018 Mar;14(3):330-339
pubmed: 29100980
J Nucl Med. 2018 Oct;59(10):1583-1589
pubmed: 29674420
Neurology. 2005 Dec 27;65(12):1863-72
pubmed: 16237129
Brain. 2019 Mar 1;142(3):744-759
pubmed: 30789229
Psychol Med. 2018 Oct;48(14):2384-2390
pubmed: 29362011
Neurology. 2020 Dec 15;95(24):e3257-e3268
pubmed: 32989106